Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface

Journal of Medical Virology

Volumn 74, Issue 2, 2004, Pages 262-271

  Andersen, Jeanette H ^a   Jenssen, Håvard ^a   Sandvik, Kjersti ^a   Gutteberg, Tore J ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Antiviral activity; Glycosaminoglycans; Herpes virus

Indexed keywords

ANTIINFECTIVE AGENT; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; IMMUNOGLOBULIN; LACTOFERRICIN; LACTOFERRICIN B; LACTOFERRIN; PEPSIN A; PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIUM; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; DEFENSE MECHANISM; DRUG MECHANISM; FUNGUS; HERPES SIMPLEX VIRUS; HOST CELL; IMMUNE RESPONSE; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOREGULATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; TRANSMISSION ELECTRON MICROSCOPY; VERO CELL; VIRUS; VIRUS ADSORPTION; VIRUS CELL INTERACTION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; CHO CELLS; CRICETINAE; HEPARITIN SULFATE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; LACTOFERRIN; MICROSCOPY, ELECTRON; VERO CELLS;

FUNGI; HERPESVIRIDAE; SIMPLEXVIRUS;

EID: 4344615913     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20171     Document Type: Article

References (43)

1. Andersen JH, Osbakk SA, Vorland LH, Traavik T, Gutteberg TJ. 2001. Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res 51:141-149.
2. Andersen JH, Jenssen H, Gutteberg TJ. 2003. Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. Antiviral Res 58:209-215.
3. Banfield BW, Leduc Y, Esford L, Schubert K, Tufaro F. 1995. Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: Evidence for a proteoglycan-independent virus entry pathway. J Virol 69:3290-3298.
4. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M. 1992. Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1121:130-136.
5. Britigan BE, Lewis TS, Waldschmidt M, McCormick ML, Krieg AM. 2001. Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. J Immunol 167:2921-2928.
6. Bullen JJ, Armstrong JA. 1979. The role of lactoferrin in the bactericidal function of polymorphonuclear leucocytes. Immunology 36:781-791.
7. Dean HJ, Terhune SS, Shieh MT, Susmarski N, Spear PG. 1994. Single amino acid substitutions in gD of herpes simplex virus 1 confer resistance to gD-mediated interference and cause cell-type-dependent alterations in infectivity. Virology 199:67-80.
8. Di Biase AM, Pietrantoni A, Tinari A, Siciliano R, Valenti P, Antonini G, Seganti L, Superti F. 2003. Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity. J Med Virol 69:495-502.
9. Dingwell KS, Johnson DC. 1998. The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions. J Virol 72:8933-8942.
10. Futaki S. 2002. Arginine-rich peptides: Potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int J Pharm 245:1-7.
11. Garre C, Bianchi-Scarra G, Sirito M, Musso M, Ravazzolo R. 1992. Lactoferrin binding sites and nuclear localization in K562(S) cells. J Cell Physiol 153:477-482.
12. Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG. 1998. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280:1618-1620.
13. Gruenheid S, Gatzke L, Meadows H, Tufaro F. 1993. Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J Virol 67:93-100.
14. Harmsen MC, Swart PJ, de Bethune MP, Pauwels R, De Clercq E, The TH, Meijer DK. 1995. Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro [see comments]. J Infect Dis 172:380-388.
15. Hasegawa K, Motsuchi W, Tanaka S, Dosako S. 1994. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn J Med Sci Biol 47:73-85.
16. Herold BC, Gerber SI, Belval BJ, Siston AM, Shulman N. 1996. Differences in the susceptibility of herpes simplex virus types I and 2 to modified heparin compounds suggest serotype differences in viral entry. Virol 70:3461-3469.
17. Herz J, Strickland DK. 2001. LRP: A multifunctional scavenger and signaling receptor. J Clin Invest 108:779-784.
18. Hwang PM, Zhou N, Shan X, Arrowsmith CH, Vogel HJ. 1998. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry 37:4288-4298.
19. Ji ZS, Mahley RW. 1994. Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler Thromb 14:2025-2031.
20. Levay PF, Viljoen M. 1995. Lactoferrin: A general review. Haematologica 80:252-267.
21. Mann DM, Romm E, Migliorini M. 1994. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J Biol Chem 269:23661-23667.
22. Marchetti M, Longhi C, Conte MP, Pisani S, Valenti P, Seganti L. 1996. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral Res 29:221-231.
23. Marchetti M, Pisani S, Antonini G, Valenti P, Seganti L, Orsi N. 1998. Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2. Biometals 11:89-94.
24. Masson PL, Heremans JF, Dive C. 1966. An iron-binding protein common to many external secretions. Clin Chim Acta 14:735-739.
25. McCormick C, Leduc Y, Martindale D, Mattison K, Esford LE, Dyer AP, Tufaro F. 1998. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat Genet 19:158-161.
26. Metz-Boutigue MH, Jolles J, Mazurier J, Schoentgen F, Legrand D, Spik G, Montreuil J, Jolles P. 1984. Human lactotransferrin: Amino acid sequence and structural comparisons with other transferrins. Eur J Biochem 145:659-676.
27. Montgomery RI, Warner MS, Lum BJ, Spear PG. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436.
28. Nakielny S, Dreyfuss G. 1999. Transport of proteins and RNAs in and out of the nucleus. Cell 99:677-690.
29. Penco S, Pastorino S, Bianchi-Scarra G, Garre C. 1995. Lactoferrin down-modulates the activity of the granulocyte macrophage colony-stimulating factor promoter in interleukin-1 beta-stimulated cells. J Biol Chem 270:12263-12268.
30. Penco S, Scarfi S, Giovine M, Damonte G, Millo E, Villaggio B, Passalacqua M, Pozzolini M, Garre C, Benatti U. 2001. Identification of an import signal for, and the nuclear localization of, human lactoferrin. Biotechnol Appl Biochem 34:151-159.
31. Rochard E, Legrand D, Lecocq M, Hamelin R, Crepin M, Montreuil J, Spik G. 1992. Characterization of lactotransferrin receptor in epithelial cell lines from non-malignant human breast, benign mastopathies and breast carcinomas. Anticancer Res 12:2047-2051.
32. Shieh MT, WuDunn D, Montgomery RI, Esko JD, Spear PG. 1992. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J Cell Biol 116:1273-1281.
33. Shukla D, Spear PG. 2001. Herpesviruses and heparan sulfate: An intimate relationship in aid of viral entry. J Clin Invest 108:503-510.
34. Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH, Eisenberg RJ, Rosenberg RD, Spear PG. 1999. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99:13-22.
35. Tomita M, Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K. 1991. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J Dairy Sci 74:4137-4142.
36. Trybala E, Liljeqvist JA, Svennerholm B, Bergstrom T. 2000. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. J Virol 74:9106-9114.
37. Van Der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK. 2001. Antiviral activities of lactoferrin. Antiviral Res 52:225-239.
38. Vives E, Brodin P, Lebleu B. 1997. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272:16010-16017.
39. Vorland LH. 1999. Lactoferrin: A multifunctional glycoprotein. APMIS 107:971-981.
40. Warner MS, Geraghty RJ, Martinez WM, Montgomery RI, Whitbeck JC, Xu R, Eisenberg RJ, Cohen GH, Spear PG. 1998. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246:179-189.
41. Weinberg ED. 2001. Human lactoferrin: A novel therapeutic with broad spectrum potential. J Pharm Pharmacol 53:1303-1310.
42. Whitley RJ. 1995. Herpes Simplex viruses. In: Fields BN, Knipe DM, Howley PM, editors. Virology. New York: Raven Press, pp 2297-2342.
43. Wu HF, Monroe DM, Church FC. 1995. Characterization of the glycosaminoglycan-binding region of lactoferrin. Arch Biochem Biophys 317:85-92.